Inositol phosphate responses in portal veins from portal hypertensive rats: Receptor- and nonreceptor-mediated responses

Journal of Hepatology

Volumn 26, Issue 2, 1997, Pages 376-381

  Huang, Yi Tsau ^a   Chang, Shu Pau ^a   Lin, Han Chieh ^a,b   Yang, May C M ^a,c   Hong, Chuang Ye ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Georgetown Univ School of Medicine   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

G proteins; portal hypertension; portal vein; 3H inositol phosphates

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; INOSITOL PHOSPHATE; PHENYLEPHRINE; PHOSPHOLIPASE C;

ANIMAL EXPERIMENT; ARTICLE; ISOTOPE LABELING; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0031039662     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80055-4     Document Type: Article

References (47)

1. Benoit JN, Granger DN. Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis. 6:1986;287-298.
2. Genecin P, Groszmann RJ. The biology of portal hypertension. Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA. 3rd Edn The Liver: Biology and Pathobiology. 1994;1327-1341 Raven Press, New York.
3. Kiel JW, Pitts V, Benoit JN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats. Am J Physiol. 248:1985;G192-G195.
4. 1-adrenoceptors of portal hypertensive rats. Br J Pharmacol. 111:1994;439-444.
5. Murray BM, Paller MS. Decreased pressor reactivity to angiostensin II in cirrhotic rats: evidence for a post-receptor defect in angiostensin action. Circ Res. 57:1985;424-431.
6. Sitzmann JV, Li S-S, Wu Y-P, Groszmann RJ, Buckley GB. Decreased mesenteric vascular response to angiostensin II in portal hypertension. J Surg Res. 48:1990;341-344.
7. Mesh CJ, Joh T, Korthuis RJ, Granger DN, Benoit JN. Intestinal vascular sensitivity to vasopressin in portal hypertensive rats. Gastroenterology. 100:1991;916-921.
8. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology. 103:1992;235 - 239.
9. Cummings SA, Groszmann RJ, Kaumann AJ. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats. Br J Pharmacol. 89:1986;501-513.
10. Kaumann AJ, Groszmann RJ. Catecholamines relax portal and mesenteric veins from normal and portal hypertensive rats. Am J Physiol. 257:1989;G977-G981.
11. Wong F, Bomzon A, Logan A, Blendis L. Effects of sodium status on the venous response to noradrenaline infusion in pre-ascitic cirrhosis. Clin Sci. 88:1995;525-531.
12. Hadengue A, Moreau R, Guadin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis. A study of the response to acute blood volume expansion. Hepatology. 15:1992;809-815.
13. Ingles AC, Hernandez I, Garcia-Estan J, Quesada T, Carbonell LE. Increased total vascular capacity in conscious cirrhotic rats. Gastroenterology. 103:1992;275-281.
14. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 372:1994;231-236.
15. Walsh MP. Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol. 72:1994;919-936.
16. Huang Y-T, Lin H-C, Yu P-C, Lee F-Y, Tsai Y-T, Lee S-D, Yang MC-M. Decreased vascular reactivity of portal vein in rats with portal hypertension. J Hepatol. 24:1996;194-199.
17. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol. 240:1981;G371-G375.
18. Huang Y-T, Hamilton CA, Reid JL. Endothelin stimulates phosphatidylinositol hydrolysis in rat vascular smooth muscle. J Hypertens. 7:1989;703-705.
19. Huang Y-T, Yu P-C, Lee M-F, Lin H-C, Hong C-Y, Yang MCM. Decreased vascular contractile and inositol phosphate responses in portal hypertensive rats. Can J Physiol Pharmacol. 73:1995;378-382.
20. Nixon GF, Hamilton CA, Wadsworth RM, Reid JL. Inositol phosphate formation in arterial smooth muscle from rabbits with perinephritis hypertension. J Hypertens. 8:1990;1155-1160.
21. Pizcueta MP, Casamitjana R, Bosch J, Rodes J. Decreased systematic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. Am J Physiol. 258:1990;G191-G195.
22. Sitzmann JV, Li S-S, Lin P-W. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension. J Surg Res. 47:1989;208-211.
23. Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, Lebrec D. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology. 18:1993;621-627.
24. Lee F-Y, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology. 16:1992;1043-1048.
25. Huang Y-T, Lo J-W, Lin H-C, Tsai Y-T, Hong C-Y, Yang MCM. Change in vascular cAMP and cGMP contents in portal hypertensive rats. Pharmacology. 50:1995;86-91.
26. Cahill PA, Foster C, Redmond EM, Wu Y, Sitzmann JV, Gingalewski C. Enhanced nitric oxide synthase activity in portal hypertensive rats. Hepatology. 22:1995;598-606.
27. Niederberger M, Gines P, Tsai P, Martin P-Y, Morris K, Weigert A, McMurty I, Schrier RW. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology. 21:1995;1625-1631.
28. Laffi G, Marra F, Falli P, Ruggiero M, Cecchi E, Carloni V, Giotti A, Gentilini P. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology. 105:1993;148-156.
29. Vane JR, Anggard EE, Botting RM. Regulatory function of the vascular endothelium. N Engl J Med. 323:1990;27-37.
30. Itoh K, Kanmura Y, Kuriyama H, Sasaguri T. Nitroglycerine and isoprenaline-induced vasolidation: assessment from the action of cyclic nucleotides. Br J Pharmacol. 84:1985;393-406.
31. 2+ levels in cultured vascular smooth muscle cells. J Biol Chem. 264:1989;1146-1155.
32. Rapoport RM. Cyclic guanosine monophosphate inhibition of contraction and hydrolysis of phosphatidylinositols in rat aorta. Circ Res. 58:1986;407-410.
33. 2+ influx and contraction in vascular smooth muslce. Jpn J Pharmacol. 59:1992;263-265.
34. Jones LG, Goldstein D, Brown JH. Guanine nucleotide-dependent inositol triphosphate formation in chick heart cells. Circ Res. 62:1988;299-305.
35. Bova S, Padrini R, Goldman WF, Berman DM, Cargnelli G. On the mechanism of vasodilating action of berberine: possible role of inositol lipid signaling system. J Pharmacol Exp Ther. 261:1992;318-323.
36. Sitzmann JV, Wu Y, Aguilera G, Cahill PA, Burns RC. Loss of angiostensin-II receptors in portal hypertensive rabbits. Hepatology. 22:1995;559-564.
37. Lepretre N, Mironneau J, Arnaudeau S, Tanfin Z, Harbon S, Guillon G, Ibarrondo J. Activation of alpha-1A adrenoceptors mobilizes calcium from the intracellular stores in myocytes from rat portal vein. J Pharmacol Exp Ther. 268:1994;167-174.
38. Pelet C, Mironneau C, Rakotoarisoa L, Neuilly G. Angiostensin II receptor subtypes and contractile responses in portal veins smooth muscle. Eur J Pharmacol. 279:1995;15-24.
39. Milligan G. Signal sorting by G-protein-linked receptors. Adv Pharmacol. 32:1995;1-29.
40. il and the mechanisms of GTP hydrolysis. Science. 265:1994;1405-1412.
41. Cahill PA, Wu Y, Sitzmann JV. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J Clin Invest. 93:1994;2691-2700.
42. Atucha NM, Ortiz MC, Martinez C, Quesada T, Garcia-Estan J. Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension. Br J Pharmacol. 118:1996;277-282.
43. Huang Y-T, Wang G-F, Yang MCM, Chang S-P, Lin H-C, Hong C-Y. Vascular responsiveness in aorta from portal hypertensive rats: possible sites of involvement. J Pharmacol Exp Ther. 278:1996;535-541.
44. Wu Z-Y, Benoit N. Nonreceptor-mediated intestinal vasoconstriction in portal hypertensive rats. Am J Physiol. 267:1994;H370-H375.
45. Ohanian V, Ohanian J, Shaw L, Scarth S, Parker PJ, Heagerty AM. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res. 78:1996;806-812.
46. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 248:1985;G618-G625.
47. Malmqvist U, Arner A. Contractile properties during development of hypertrophy of the smooth muscle in the rat portal vein. Acta Physiol Scand. 133:1988;49-61.